Lotte Biologics Co., Ltd announced a private placement of 3,700,000 common shares of KRW 65,000 each for the gross proceeds of KRW 240.5 billion on October 20, 2022. The transaction has been approved by shareholders of the company. Discount rate or premium rate (%) compared to par value per share is KRW 1,200.